Advertisements


Cipher Pharmaceuticals Reports Q2 2018 Results

Cipher Pharmaceuticals Reports Q2 2018 Results Canada NewsWire MISSISSAUGA, ON, Aug. 10, 2018 Canadian product revenue increased 33% MISSISSAUGA, ON, Aug. 10, 2018 /CN.....»»

Category: earningsSource: benzingaAug 10th, 2018

Cipher Pharmaceuticals Reports Q2 2018 Results

Cipher Pharmaceuticals Reports Q2 2018 Results Canada NewsWire MISSISSAUGA, ON, Aug. 10, 2018 Canadian product revenue increased 33% MISSISSAUGA, ON, Aug. 10, 2018 /CN.....»»

Category: earningsSource: benzingaAug 10th, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, February 12th at 11:30 A.....»»

Category: earningsSource: benzingaFeb 11th, 2019

Eton Pharmaceuticals Reports Third Quarter Results and Business Update

Licensed High-Value Injectable Product Candidate Successfully Completed Initial Public Offering DEER PARK, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ:ETON), a specialty pharmaceutical company focused on developing and.....»»

Category: earningsSource: benzingaDec 20th, 2018

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results with consistent year over year sales

TORONTO, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Polyd.....»»

Category: earningsSource: benzingaDec 17th, 2018

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Off.....»»

Category: earningsSource: benzingaNov 14th, 2018

RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

RXi Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights.....»»

Category: earningsSource: benzingaNov 14th, 2018

Biohaven Pharmaceuticals Reports Third Quarter 2018 Financial And Recent Business Results

NEW HAVEN, Conn., Nov. 14, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN), a clinical-stage biopharmaceutical comp.....»»

Category: earningsSource: benzingaNov 14th, 2018

Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, In.....»»

Category: earningsSource: benzingaNov 13th, 2018

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmac.....»»

Category: earningsSource: benzingaNov 13th, 2018

Cumberland Pharmaceuticals Reports Third Quarter 2018 Financial Results

Cumberland Pharmaceuticals Reports Third Quarter 2018 Financial Results.....»»

Category: earningsSource: benzingaNov 13th, 2018

Cipher Pharmaceuticals, Inc. (CPHRF) CEO Robert Tessarolo on Q3 2018 Results - Earnings Call Transcript

Cipher Pharmaceuticals, Inc. (CPHRF) CEO Robert Tessarolo on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 9th, 2018

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2019 Ended September 30, 2018 and Provides Conference Call Information

Conference Call Scheduled for Monday, November 12th .....»»

Category: earningsSource: benzingaNov 9th, 2018

Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results

-- Presented Updated Data from Phase 2 Basket Studies in Bardet-Biedl Syndrome (BBS) and Alström Syndrome at the 57th.....»»

Category: earningsSource: benzingaNov 9th, 2018

Avadel Pharmaceuticals Reports Third Quarter 2018 Financial Results

DUBLIN, Ireland, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NA.....»»

Category: earningsSource: benzingaNov 5th, 2018

AcelRx Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., Nov. 2, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:.....»»

Category: earningsSource: benzingaNov 2nd, 2018

Polydex Reports Second Quarter Financial Results

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC:POLXF) (the "Company") today announced financial results for the second quarter of the 2019 fiscal year. The three-month and six-month periods ending July 31, 2018 (togeth.....»»

Category: earningsSource: benzingaSep 19th, 2018

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2018 Financial Results and Provides R&D and Business Update.....»»

Category: earningsSource: benzingaSep 13th, 2018

Crinetics Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a clinical stage pharmaceutical company focused on the discovery, development a.....»»

Category: earningsSource: benzingaAug 30th, 2018

RXi Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

RXi Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights.....»»

Category: earningsSource: benzingaAug 14th, 2018

Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

Enrollment continues in Phase 3 GBM brain cancer trial Key European patent validated covering oral formulation of TSC Preparing for Phase 2 stroke trial with in-am.....»»

Category: earningsSource: benzingaAug 13th, 2018